Skip navigation
Página inicial
Percorrer
Comunidades y
Colecciones
Vea ítems por:
Fecha de Publicación
Autor
Título
Assunto
Sobre
Sobre el Repositorio Institucional
Políticas de uso
FAQs (Preguntas Frecuentes)
Créditos
Estadísticas de Acceso
Registrarse para:
Mi Repositorio
Recibir actualizaciones
por correo
Editar perfil
Repositório PUCRS
Visualizando por Autor André Poisl Fay
Ir a:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
o entre con las primeras letras:
Ordenar por:
Título
Fecha de Publicación
Fecha de Sumisión
Para:
Ascendente
Descendente
Resultados/Página
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Autores/Registro:
Todos
1
3
5
10
15
20
25
30
35
40
45
50
Mostrando reg. 1 a 20 de 65
siguiente ►
Fecha de Publicación
Título
Autor(s)
2021
A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415)
MALUF, FERNANDO C.
;
SCHUTZ, FABIO A.
;
CRONEMBERGER, EDUARDO H.
, etc.
2022
A Systematic Review and Meta-Analysis of the Role of Immune Checkpoint Inhibitors (ICI) as Adjuvant Treatment for Localized High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC)
MONTEIRO, FERNANDO SABINO M.
;
SOARES, ANDREY
;
SOUZA, VINICIUS CARRERA
, etc.
2020
Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)
Andrey Soares
;
MONTEIRO, FERNANDO SABINO MARQUES
;
MALUF, FERNANDO C.
, etc.
2018
Análise da expressão imuno-histoquímica do fator tecidual no carcinoma gástrico: correlações com prognóstico e sobrevida.
TONETO, MARCELO GARCIA
;
DEPAULA, PEDRO LUCAS
;
DEBON, LETÍCIA
, etc.
2018
Análise da expressão imuno-histoquímica do fator tecidual no carcinoma gástrico: correlações com prognóstico e sobrevida.
TONETO, MARCELO GARCIA
;
DEPAULA, PEDRO LUCAS
;
DEBON, LETÍCIA
, etc.
2015
Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinoma
Joaquim Bellmunt
;
MULLANE, S. A.
;
WERNER, L.
, etc.
2016
Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy
BELLMUNT, JOAQUIM
;
ZHOU, CHENSHENG WILLA
;
MULLANE, STEPHANIE A
, etc.
2019
Blocking the PD-1/PD-L1 axis in advanced prostate cancer: are we moving in the right direction?
André Poisl Fay
;
ANTONARAKIS, EMMANUEL S.
2016
Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy
TEMPLETON, ARNOUD J.
;
KNOX, JENNIFER J.
;
LIN, XUN
, etc.
2015
Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled Trial
CHOUEIRI, T. K.
;
FIGUEROA, D. J.
;
André Poisl Fay
, etc.
2015
Cost of preventing an event (COPE) of enzalutamide versus abiraterone plus prednisone in men with metastatic castration-resistant prostate cancer under the Brazilian private health care system perspective
Stephen Doral Stefani
;
Vanessa Teich
;
André Poisl Fay
, etc.
2015
Cost of preventing an event (COPE) of enzalutamide versus abiraterone plus prednisone in men with metastatic castration-resistant prostate cancer under the Brazilian private health care system perspective
Stephen Doral Stefani
;
Vanessa Teich
;
André Poisl Fay
, etc.
2015
Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma.
CALLEA, MARCELLA
;
ALBIGES, LAURENCE
;
Mampta Gupta
, etc.
2017
Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials
MOREIRA, RAPHAEL B.
;
Marcio Debiasi
;
FRANCINI, EDOARDO
, etc.
2017
Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials
MOREIRA, RAPHAEL B.
;
Marcio Debiasi
;
FRANCINI, EDOARDO
, etc.
2020
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
VAN DER HEIJDEN, MICHIEL S
;
GALSKY, MATTHEW D
;
PETRYLAK, DANIEL P
, etc.
2015
Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma
ALBIGES, LAURENCE
;
André Poisl Fay
;
XIE, WANLING
, etc.
2017
ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis
URUN, YUKSEL
;
LEOW, JEFFREY J.
;
André Poisl Fay
, etc.
2020
First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis
MONTEIRO, FERNANDO SABINO M.
;
SOARES, ANDREY
;
DEBIASI, MÁRCIO
, etc.
2015
HER2 as a target in invasive urothelial carcinoma
BELLMUNT, JOAQUIM
;
WERNER, LILLIAN
;
BAMIAS, ARISTOTLE
, etc.